Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$EVH Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.25 up 43.18% YoY
• Reported revenue of $652.52M up 46.86% YoY
• Evolent Health, Inc. is raising its 2026 revenue guidance range to $2.6 billion to $2.7 billion and is tightening its Adjusted EBITDA range to $120 million to $135 million for 2026.Price since post
Advertisement|Remove ads.